The resulting glycosylation changes suppress the activation, cytokine production, and cytotoxic function of CD8+ T cells and NK cells, facilitating immune evasion, tumor progression, and metastasis in bladder cancer [65,66]. The gene discussed is CD8A; the disease is urinary bladder cancer.